Header Logo

Mahdi Garelnabi BS., MLT, MSc., Ph.D

Title
InstitutionUniversity of Massachusetts Lowell
DepartmentClinicalLab & NutritionalSci
AddressWeed Hall, Room 103
Lowell, MA 01854
Phone978-934-4528
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Khraishah H, Daher R, Garelnabi M, Karere G, Welty FK. Sex, Racial, and Ethnic Disparities in Acute Coronary Syndrome: Novel Risk Factors and Recommendations for Earlier Diagnosis to Improve Outcomes. Arterioscler Thromb Vasc Biol. 2023 08; 43(8):1369-1383. PMID: 37381984.
      Citations:    Fields:    Translation:Humans
    2. Moser B, Moore D, Khadka B, Lyons C, Foxall T, Andam CP, Parker CJ, Ochin C, Garelnabi M, Sevigny J, Thomas WK, Bigornia S, Dao MC. Association between inflammation, lipopolysaccharide binding protein, and gut microbiota composition in a New Hampshire Bhutanese refugee population with a high burden of type 2 diabetes. Front Nutr. 2022; 9:1059163. PMID: 36687728.
      Citations:    
    3. Ochin CC, Wilson T, Garelnabi M. Dietary Oxidized Linoleic Acids Modulate Fatty Acids in Mice. J Lipid Atheroscler. 2022 May; 11(2):197-210. PMID: 35656146.
      Citations:    
    4. Garelnabi M, Cowdin M, Fang Y, Shrestha B, Ushio-Fukai M, Aikawa E, Graham G, Molema G, Yanagisawa H, Aikawa M. Embracing Diversity, Equity, and Inclusion in the Scientific Community-Viewpoints of the Diversity, Equity, and Inclusion Committee of the North American Vascular Biology Organization. Front Cardiovasc Med. 2022; 9:863256. PMID: 35463765.
      Citations:    
    5. Guan Y, Ebrahimzadeh SA, Cheng CH, Chen W, Leung T, Bigornia S, Palacios N, Garelnabi MO, Scott T, Bhadelia R, Tucker KL, Koo BB. Association of Diabetes and Hypertension With Brain Structural Integrity and Cognition in the Boston Puerto Rican Health Study Cohort. Neurology. 2022 04 12; 98(15):e1534-e1544. PMID: 35354581.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    6. Punch E, Klein J, Diaba-Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis. J Am Heart Assoc. 2022 02; 11(3):e023328. PMID: 35048716.
      Citations: 11     Fields:    Translation:Humans
    7. Grech J, Chan MV, Ochin C, Lachapelle A, Thibord F, Schneider Z, Nkambule BB, Armstrong PCJ, de Melendez CW, Tucker KL, Garelnabi M, Warner TD, Chen MH, Johnson AD. Serotonin-Affecting Antidepressant Use in Relation to Platelet Reactivity. Clin Pharmacol Ther. 2022 04; 111(4):909-918. PMID: 34939182.
      Citations: 3     Fields:    Translation:HumansCells
    8. Merchant N, Garelnabi M, Karabina SA, Meilhac O, Narasimhulu CA, Penumetcha M, Lehner A, Earle D, Song M, Kim JG, Raghavamenon A, Rajagopalan S, Khan BV, Santanam N. Sampath Parthasarathy, PhD, MBA, 1947-2020. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1251-1252. PMID: 33760634.
      Citations:    Fields:    
    9. Bardon KM, Garelnabi M. The impact of altered mechanobiology on aortic valve pathophysiology. Arch Biochem Biophys. 2020 09 30; 691:108463. PMID: 32590066.
      Citations: 4     Fields:    Translation:HumansCells
    10. Piper K, Garelnabi M. Eicosanoids: Atherosclerosis and cardiometabolic health. J Clin Transl Endocrinol. 2020 Mar; 19:100216. PMID: 32071878.
      Citations:    
    11. Amin KA, Homeida AM, ElMazoudy RH, Hashim KS, Garelnabi M. Corrigendum to "Dietary Lipids in Health and Disease". J Lipids. 2020; 2020:5704752. PMID: 32395348.
      Citations:    
    12. McGrail L, Garelnabi M. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases. Curr Pharm Biotechnol. 2020; 21(7):578-586. PMID: 31713494.
      Citations: 2     Fields:    Translation:HumansAnimals
    13. Wu T, Mazhar Z, Alsayrafi D, Garelnabi M. p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in Atherosclerosis. Cardiovasc Hematol Agents Med Chem. 2020; 18(2):151-157. PMID: 31738151.
      Citations: 4     Fields:    Translation:AnimalsCells
    14. Amin KA, Homeida AM, El Mazoudy RH, Hashim KS, Garelnabi M. Dietary Lipids in Health and Disease. J Lipids. 2019; 2019:5729498. PMID: 31355001.
      Citations:    
    15. Ochin CC, Garelnabi M. Berberine Encapsulated PLGA-PEG Nanoparticles Modulate PCSK-9 in HepG2 Cells. Cardiovasc Hematol Disord Drug Targets. 2018; 18(1):61-70. PMID: 29422010.
      Citations: 6     Fields:    Translation:HumansCells
    16. Garelnabi M, Ainsworth G, Mahini H, Jamil N, Ochin C. Dietary Oxidized Linoleic Acid Modulates Plasma Lipids beyond Triglycerides Metabolism. J Lipids. 2017; 2017:1645828. PMID: 29318046.
      Citations:    
    17. Mazhar Z, Hughes A, Garelnabi M. Targeting the Role of Lipoprotein (a) in Stroke. Cardiovasc Hematol Disord Drug Targets. 2017; 17(1):64-72. PMID: 28429674.
      Citations: 1     Fields:    Translation:HumansAnimals
    18. Garelnabi M, Younis A. Paraoxonase-1 enzyme activity assay for clinical samples: validation and correlation studies. Med Sci Monit. 2015 Mar 27; 21:902-8. PMID: 25814092.
      Citations: 3     Fields:    Translation:Humans
    19. Younis A, Hawkins K, Mahini H, Butler W, Garelnabi M. Serum tumor necrosis factor-a, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility. J Assist Reprod Genet. 2014 Nov; 31(11):1445-51. PMID: 25186501.
      Citations: 12     Fields:    Translation:Humans
    20. Garelnabi M, Mahini H, Wilson T. Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation. J Int Soc Sports Nutr. 2014; 11:22. PMID: 24890098.
      Citations: 10     Fields:    
    21. Uzoigwe JC, Prum T, Bresnahan E, Garelnabi M. The emerging role of outdoor and indoor air pollution in cardiovascular disease. N Am J Med Sci. 2013 Aug; 5(8):445-53. PMID: 24083218.
      Citations:    
    22. Litvinov D, Mahini H, Garelnabi M. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci. 2012 Nov; 4(11):523-32. PMID: 23181222.
      Citations:    
    23. Garelnabi M, Lor K, Jin J, Chai F, Santanam N. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem. 2013 Jan; 46(1-2):12-9. PMID: 23000317.
      Citations: 26     Fields:    Translation:HumansAnimals
    24. Younis A, Clower C, Nelsen D, Butler W, Carvalho A, Hok E, Garelnabi M. The relationship between pregnancy and oxidative stress markers on patients undergoing ovarian stimulations. J Assist Reprod Genet. 2012 Oct; 29(10):1083-9. PMID: 22798064.
      Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
    25. Garelnabi M, Gupta V, Mallika V, Bhattacharjee J. Platelet nitric oxide signaling system in patients with coronary artery disease. Ann Vasc Dis. 2011; 4(2):99-105. PMID: 23555437.
      Citations:    
    26. Garelnabi M, Litvinov D, Parthasarathy S. Evaluation of a gas chromatography method for azelaic acid determination in selected biological samples. N Am J Med Sci. 2010 Sep; 2(9):397-402. PMID: 22558586.
      Citations:    
    27. Garelnabi M, Gupta V, Mallika V, Bhattacharjee J. Platelets oxidative stress in Indian patients with ischemic heart disease. J Clin Lab Anal. 2010; 24(1):49-54. PMID: 20088006.
      Citations: 5     Fields:    Translation:HumansCells
    28. Garelnabi M, Veledar E, Abramson J, White-Welkley J, Santanam N, Weintraub W, Parthasarathy S. Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women. J Clin Lab Anal. 2010; 24(2):100-5. PMID: 20333763.
      Citations: 3     Fields:    Translation:Humans
    29. Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Oxidized low-density lipoprotein. Methods Mol Biol. 2010; 610:403-17. PMID: 20013192.
      Citations: 97     Fields:    Translation:HumansCells
    30. Litvinov D, Selvarajan K, Garelnabi M, Brophy L, Parthasarathy S. Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice. Atherosclerosis. 2010 Apr; 209(2):449-54. PMID: 19880116.
      Citations: 19     Fields:    Translation:AnimalsCells
    31. Raghavamenon A, Garelnabi M, Babu S, Aldrich A, Litvinov D, Parthasarathy S. Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis. Antioxid Redox Signal. 2009 Jun; 11(6):1237-48. PMID: 19186999.
      Citations: 16     Fields:    Translation:HumansCells
    32. Garelnabi MO, Brown WV, Le NA. Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clin Biochem. 2008 Oct; 41(14-15):1250-4. PMID: 18703037.
      Citations: 7     Fields:    Translation:Humans
    33. Jaichander P, Selvarajan K, Garelnabi M, Parthasarathy S. Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. J Lipid Res. 2008 Oct; 49(10):2142-8. PMID: 18519978.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    34. Parthasarathy S, Litvinov D, Selvarajan K, Garelnabi M. Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta. 2008 May; 1781(5):221-31. PMID: 18406361.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    35. Garelnabi M, Selvarajan K, Litvinov D, Santanam N, Parthasarathy S. Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms. Atherosclerosis. 2008 Aug; 199(2):304-9. PMID: 18243209.
      Citations: 7     Fields:    Translation:Animals
    36. Wei C, Penumetcha M, Santanam N, Liu YG, Garelnabi M, Parthasarathy S. Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effects. Biochim Biophys Acta. 2005 May 25; 1723(1-3):124-7. PMID: 15820521.
      Citations: 14     Fields:    Translation:Animals
    37. Garelnabi M, Paradhan P. Splenectomy may not influence glutathione metabolism in children with beta-thalassaemia major. Turk J Haematol. 2005 Mar 05; 22(1):25-30. PMID: 27264514.
      Citations: 1     Fields:    
    For assistance with using Profiles, please contact Profiles Support
    Garelnabi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (156)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _